Vaccination hesitancy and the "myth" on mRNA-based vaccines in Italy in the COVID-19 era: Does urgency meet major safety criteria?

Chirumbolo, Salvatore

Chirumbolo, Salvatore.

Chirumbolo S; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.

J Med Virol ; 93(7): 4049-4053, 2021 07.

Article in English | MEDLINE | ID: covidwho-1118170

ABSTRACT

ABSTRACT

Coronavirus disease 2019 (COVID-19) vaccination campaign in Italy has started with a huge perplexity about vaccine efficacy, vaccine-borne adverse effects and vaccine clinical trial studies. In this commentary I tried to elucidate these issues, which represent a fundamental topic to be thoroughly addressed in COVID-19 pandemic.

Subject(s)

COVID-19 Vaccines; COVID-19/prevention & control; Vaccination Refusal; Vaccines, Synthetic; 2019-nCoV Vaccine mRNA-1273; Anaphylaxis/etiology; BNT162 Vaccine; COVID-19/epidemiology; COVID-19/immunology; COVID-19 Vaccines/adverse effects; COVID-19 Vaccines/immunology; Health Knowledge, Attitudes, Practice; Humans; Italy/epidemiology; Liposomes/adverse effects; Mass Vaccination; Nanoparticles/adverse effects; Pandemics/prevention & control; Polyethylene Glycols/adverse effects; Vaccines, Synthetic/adverse effects; Vaccines, Synthetic/immunology

Keywords

administrative law; coronavirus; political science; public policy; social science; virus classification

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines, Synthetic / Vaccination Refusal / COVID-19 Vaccines / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Country/Region as subject: Europa Language: English Journal: J Med Virol Year: 2021 Document Type: Article Affiliation country: Jmv.26922

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google